Previous 10 | Next 10 |
WAYNE, Pa. and ROCKVILLE, Md., June 01, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board, will present at the Jefferies Healthcare Conference on Friday, June 9, 2023 at 11:00 a.m. ET at the...
Avalo’s SAB is comprised of key opinion leaders in immunology and the LIGHT-signaling network WAYNE, Pa. and ROCKVILLE, Md., May 22, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced the appointment of Dr. Michael Croft and Dr. Jeff Edelson to the company...
2023-05-18 12:42:08 ET Gainers: Enveric Biosciences ( ENVB ) +112% . Phio Pharmaceuticals ( PHIO ) +46% . WANG & LEE GROUP ( WLGS ) +34% . Alimera Sciences ( ALIM ) +29% . SciPlay Corporation ( SCPL ) +26% . Eltek ( ELT...
WAYNE, Pa. and ROCKVILLE, Md., May 15, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board, will attend and present at the ATS 2023 Respiratory Innovation Summit (RIS), hosted by the American ...
WAYNE, Pa. and ROCKVILLE, Md., May 10, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board, will present at the 2023 RBC Capital Markets Global Healthcare Conference on Tuesday, May 16, 2023 a...
2023-05-04 17:23:52 ET Avalo Therapeutics press release ( NASDAQ: AVTX ): Q1 GAAP EPS of -$0.85. Revenue of $0.48M (-100.0% Y/Y). Avalo had $16.7 million in cash and cash equivalents as of March 31, 2023, representing a $3.5 million increase compared to December 31, 20...
Topline data expected in the second quarter of 2023 from the Phase 2 PEAK Trial of AVTX-002 in non-eosinophilic asthma (NEA) Disclosed cash of approximately $16.7 million as of March 31, 2023 WAYNE, Pa. and ROCKVILLE, Md., May 04, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nas...
2023-04-25 06:35:25 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Personalized medicine stocks are hot right now. This form of medicine based on the particular genes, proteins, and other substances in a person’s body. It promises to revolutio...
2023-04-12 16:14:29 ET Avalo Therapeutics ( NASDAQ: AVTX ) disclosed in an SEC filing Wednesday it intends to raise $375 million through a mixed shelf offering. The company plans to offer and sell common stock, preferred stock, debt securities, warrants and/or units to raise t...
2023-04-10 13:17:20 ET Gainers: GlucoTrack ( GCTK ) +193% . Kalera Public Limited Company ( KAL ) +48% . Eloxx Pharmaceuticals ( ELOX ) +48% . Avalo Therapeutics ( AVTX ) +29% . Eos Energy Enterprises ( EOSE ) +28% . Guardfor...
News, Short Squeeze, Breakout and More Instantly...
Avalo Therapeutics Inc. Company Name:
AVTX Stock Symbol:
NASDAQ Market:
Avalo Therapeutics Inc. Website:
WAYNE, Pa. and ROCKVILLE, Md., July 16, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced that Mittie Doyle, MD, FACR has joined the Company as its Chief Medical Officer. “We are thrilled to have Mittie join and grow our leadership team at an exciting...
Following FDA review, Avalo’s IND application for AVTX-009 is active allowing Avalo to proceed with its Phase 2 trial (LOTUS) to evaluate the efficacy and safety of AVTX-009 in patients with hidradenitis suppurativa WAYNE, Pa. and ROCKVILLE, Md., July 09, 2024 (GLOBE NEWSWIRE) -- Ava...
2024-07-06 21:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...